Table 2 Association between ERCC2 polymorphisms with oral cancer risks
From: Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis
No of studies | Fixed-effect | Random-effect | Phet | I-squared (%) | |
|---|---|---|---|---|---|
Rs1799793 | |||||
GA vs. GG | 3 | 1.14[0.91,1.43] | 1.13[0.80,1.61] | 0.182 | 41.2 |
AA vs. GG | 3 | 1.27[0.87,1.86] | 1.24[0.87,1.85] | 0.436 | 0.0 |
GA + AA vs. GG | 3 | 1.16[0.94,1.44] | 1.17[0.89,1.55] | 0.268 | 24.0 |
AA vs. GA + GG | 3 | 1.18[0.82,1.70] | 1.16[0.81,1.68] | 0.406 | 0.0 |
A vs. G | 3 | 1.13[0.96,1.34] | 1.13[0.96,1.34] | 0.491 | 0.0 |
Rs13181 | |||||
AC vs. AA | 6 | 1.16[0.96,1.40] | 1.17[0.90,1.51] | 0.171 | 35.5 |
CC vs. AA | 6 | 1.42[1.03,1.96] | 1.71[0.92,3.20] | 0.044 | 56.1 |
AC + CC vs. AA | 6 | 1.19[1.00,1.43] | 1.24[0.92,1.67] | 0.045 | 55.8 |
CC vs. AC + AA | 6 | 1.29[0.95,1.76] | 1.48[0.87,2.52] | 0.101 | 45.7 |
C vs. A | 6 | 1.17[1.02,1.34] | 1.23[0.94,1.62] | 0.011 | 66.1 |